eoe - search results

If you're not happy with the results, please do another search
EoE

Study: Children with Current Allergies Should Be Screened for EoE

Eosinophilic Esophagitis joins the “Atopic (Allergic) March” of early childhood.
Dupixent

Eczema Drug Makes Significant Progress as EoE Treatment

Phase II study shows promise of dupilumab as a treatment for symptoms of eosinophilic esophagitis.

End Allergies Together Funds EoE Diagnostic Research

EoE is on the rise and may increase even more once oral immunotherapy becomes commonplace. EAT is funding research into a better diagnostic.

Risk of EoE to Those That Have Outgrown Allergy to Same Food

A study asserts that individuals who have outgrown a food allergy may be at risk of developing eosinophilic esophagitis to the same food.
Tanya Ednan-Laperouse and Emma Turay

Two UK Allergy Moms Who Suffered Horrific Losses Demand an Allergy Czar. We Should...

We applaud the efforts of Ms Ednan-Laperouse and Ms Turay and believe their concept of a single person responsible for the health and safety of the allergic community should be adopted here in the US.
Palforzia Ad

How the First FDA-Approved Therapy for Peanut Allergy is Helping Families (Sponsored)

What is PALFORZIA?  PALFORZIA is a treatment for people who are allergic to peanuts. PALFORZIA can help reduce the severity of allergic reactions, including anaphylaxis,...

Dupixent (dupilumab) Study Shows Significant Improvement in Eosinophilic Esophagitis Signs and Symptoms

Phase 3 trial in (EoE) to show a significantly improved structural and histologic measures, while rapidly improving ability to swallow in patients 12 years and older
US Faster Act

The FASTER Act: What It Does and Why YOU Need to Help Pass It

FARE can't do it alone: Do your part to help pass the FASTER Act.
End Allergies Together

End Allergies Together, Responsible for Funding Important Research, is Winding Down Operations

"We are grateful to all of those who have supported us and helped E.A.T make such a significant impact on the food allergy industry."
AR101

Phase 3 Trial Data Demonstrates Consistent Safety and Efficacy of AR101 in Children and...

“Results of the European ARTEMIS trial provide further clinical validation of the safety and efficacy of AR101 for children and adolescents with peanut allergy.”